Further studies are needed to investigate whether methoxyflavones modulate upstream signaling pathways, such as NF-κB, STAT3, or mitogen-activated protein kinases (MAPKs), which are well-established drivers of inflammation and immune activation in psoriasis [9]. This evidence concerns the gene NFKB1 and psoriasis.